Lars Eric Utterman, CEO, Wolfgang Lerch, Managing Director and Thiemo Gropp, founder and member of the board to IonGate Biosciences, speak candidly about their vision for the future.
|
|
 |
Product RangeThe SURFE²R™ Workstation family enables highly precise functional screening
of transporters for high-throughput pharmaceutical discovery and development
|
|
|
|
Full-service Solutions
IonGate provides total system solutions, encompassing disposables and reagents, consulting services, and contract laboratory services |
|
|
|
Technology IonGate has developed a revolutionary, biosensor-based technology platform
– SURFE²R – that enables direct functional characterization of transporter proteins |
|
|
New: SURFE²R Workstation 5Superior performance – Small footprint
|
|
|
This semi-automated bench-top system is designed for basic research and assay development where high information content is prevalent. |
Case Study
A-M2 proton channel of the influenza A virus is a target for the anti-flu drugs amantadine and rimantadine. However,
a rapid increase of the virus resistance to these drugs was recorded in the past decade. |
|
|
|
